The study found that healthy women have higher levels of microglia compared to healthy men. Because women are at a greater risk for autoimmune disorders, it was not surprising to Cosgrove that the brain’s immune system in women might also be more active. “The healthy brains of women have higher levels of microglia, and that may or may not go along with the fact that women do have an increased propensity to immune-related disorders,” she says.
Among individuals with alcohol use disorder, the team found a microglial deficit in women compared to their healthy counterparts, but not in men. Previous research on primarily male cohorts with more severe alcohol use disorder, however, has shown this deficit. The current study suggests that women might start losing their microglia at earlier stages, says Cosgrove, who is also a professor of neuroscience and of radiology and biomedical imaging.
This deficit in the brain’s immune system could have significant health impacts. Based on the questionnaires of study participants with alcohol use disorder, the researchers found that women, but not men, had worsened mood and higher levels of anxiety.
Women with alcohol use disorder also had lower levels of executive functioning, which refers to the cognitive skills we use to complete everyday tasks such as planning or problem solving. The researchers found that lower levels of microglia in a brain region known as the cerebellum, in particular, were associated with worse executive function. The cerebellum plays a vital role in motor function, but also is involved in cognitive and emotional functions.
“This is a glimmer into how immune system dysfunction is associated with cognitive function,” Cosgrove says. “If you don’t have a healthy brain immune system, then other parts downstream will start to break down as well.”
Today, most available treatments for alcohol use disorder were developed based on research involving primarily men. The new study could help inform the development of novel therapeutics designed for women that target the brain’s immune system.
Cosgrove adds that the study is evidence that improving other factors known to boost immune processes—such as sleep, exercise, and healthy diet—may also help women in their recovery. While researchers still don’t know if the microglial deficit is permanent, Cosgrove says the human brain’s resilience makes her optimistic.
“You can’t solely focus on giving someone a medication to tweak their brain chemistry,” she says. “Clinicians need to take a more holistic approach.”
The research reported in this news article was supported by the National Institutes of Health (awards U54AA027989 [Yale-SCORE ORWH/NIAAA], MH110674, P01AA02747307, K01AA029706, and K24AA031345) and Yale University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.